Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
17%
Ph phase_1
1
8%
Ph phase_2
1
8%
Ph not_applicable
7
58%
Ph phase_3
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
7(58.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(9)
Other(2)

Detailed Status

Completed9
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 31 (8.3%)
Phase 42 (16.7%)
N/A7 (58.3%)

Trials by Status

not_yet_recruiting18%
unknown217%
completed975%

Recent Activity

0 active trials
Showing 5 of 12
completednot_applicable

Short-term Oral Prednisone for Acute Subjective Tinnitus

NCT05591144
completedphase_4

To Evaluate the Effect of Ginkgo Biloba Extract on Optic Nerve Head Perfusion Examined Using OCTA

NCT04846179
not_yet_recruitingnot_applicable

Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke

NCT06140888
unknownnot_applicable

Different Dosing Regimens of STOP-AST

NCT06124703
unknownnot_applicable

Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba

NCT04121728
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05591144Not Applicable

Short-term Oral Prednisone for Acute Subjective Tinnitus

Completed
NCT04846179Phase 4

To Evaluate the Effect of Ginkgo Biloba Extract on Optic Nerve Head Perfusion Examined Using OCTA

Completed
NCT06140888Not Applicable

Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke

Not Yet Recruiting
NCT06124703Not Applicable

Different Dosing Regimens of STOP-AST

Unknown
NCT04121728Not Applicable

Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba

Unknown
NCT05258123Not Applicable

Ginkgo Biloba Extract in the Treatment of Schizophrenia

Completed
NCT03425045Not Applicable

Repetitive Transcranial Magnetic Stimulation for Chronic Subjective Tinnitus

Completed
NCT01524380Not Applicable

Ginkgo Biloba Extract for Schizophrenia

Completed
NCT02425436Phase 2

Role of Ginkgo Biloba Extract in IUGR

Completed
NCT00042172Phase 4

Treatment for Early Memory Loss

Completed
NCT00010920Phase 3

Preventing Cognitive Decline With Alternative Therapies

Completed
NCT00032474Phase 1

Ginkgo Biloba Extract and the Insulin Resistance Syndrome

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12